vimarsana.com

Page 19 - தேசிய ஆர்கநைஸேஶந் க்கு ரேர் கோளாறுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Israel investigates Pfizer vaccine recipients who reported inflammation of the heart after 62 cases

Israel is investigating a small number of cases of heart inflammation among people who have been vaccinated with the Pfizer coronavirus jab.  Health officials said 62 out of 5million people given the American-made vaccine developed myocarditis, the medical name for swelling in the heart.  Pfizer said it has not seen a higher rate of the condition than would normally be expected in the population, but experts are investigating in order to be sure. Early analysis of the country s rollout suggests the condition is occurring more frequently in men under 30 and in people given both doses.  The condition often has no symptoms and heals on its own, but in some people it can cause more serious problems including heart failure or weakening of the heart.

Pentagon Tracking 14 Cases of Heart Inflammation in Troops After COVID-19 Shots

The DoD has been tracking myocarditis cases since March, according to spokesman Peter Graves.  Of the 14 cases, one patient, who tested positive for COVID-19 three months ago, developed myocarditis after their first dose of vaccine. The remaining 13 patients developed myocarditis after their second vaccine doses. Eleven received the Moderna vaccine; three got Pfizer. Military.com reporter Steve Beynon, 30, a member of the Washington, D.C., National Guard, is among the 14 military patients who developed myocarditis after his second dose of the Moderna vaccine. He was hospitalized at Walter Reed National Military Medical Center in February and spent nearly three days in the ICU, but returned to work and has since performed his National Guard duties.

CDISC and NORD Partner to Develop Data Standards for Rare Diseases

CDISC and the National Organization forRare Disorders (NORD ®) have announced a partnership to develop global data standards for rare diseases. The data standards will be released in a Therapeutic Area User Guide that will be available at no cost on the CDISC website for researchers to leverage in studies to maximize data’s full potential. According to the FDA, any disease, disorder, illness or condition affecting fewer than 200,000 people in the United States is considered rare. There are approximately 7,000 rare diseases and it’s estimated that 25-30 million Americans have rare diseases. More than 90% of rare diseases have no FDA-approved treatment. Globally, it is estimated that 350 million individuals are impacted by a rare disease.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.